For over a century, the medical community has aimed to create insulin pills for diabetes management, but the stability of insulin in the digestive tract has been a significant barrier.
Recent advancements from researchers at Kumamoto University suggest potential solutions to protect insulin from degradation, which could enable oral administration.
If successful, this development could transform the treatment landscape for millions of diabetes patients, potentially improving adherence and quality of life.